| Authors: |
Iftikhar R; Armed Forces Bone Marrow Transplant Center, National University of Medical Sciences, Rawalpindi, Pakistan. Electronic address: drraheeliftikhar@gmail.com., DeFilipp Z; Hematopoietic Cell Transplant and Cell Therapy Program, Massachusetts General Hospital, Boston, Massachusetts., DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland., Pulsipher MA; Division of Pediatric Hematology and Oncology, Intermountain Primary Children's Hospital, Huntsman Cancer Institute, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, UT., Bejanyan N; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida., Burroughs LM; Fred Hutchinson Cancer Center, Clinical Research Division and University of Washington, Seattle, Washington., Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, Florida., Arai S; Division of BMT and Cell Therapy, Department of Medicine, Stanford University Medical Center, Stanford, California., Kassim A; Division of Hematology/Oncology, The Vanderbilt Clinic, Nashville, Tennessee., Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Saldaña BJD; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington District of Columbia., Aljurf M; Adult Hematology and Stem Cell Transplant, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Hamadani M; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Carpenter PA; Fred Hutchinson Cancer Center, Clinical Research Division and University of Washington, Seattle, Washington., Antin JH; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts. |
